Balance Sheet - KalVista Pharmaceuticals, Inc. (KALV)
$(Billion, Million)| Apr-26 | Apr-25 | Apr-24 | Apr-23 | Apr-22 | Apr-21 | Apr-20 | Apr-19 | Apr-18 | Apr-17 | Apr-16 | Mar-16 | Dec-15 | Apr-15 | Dec-14 | Apr-14 | Apr-13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 300.21 | 187.65 | 210.40 | 149.38 | 166.20 | 248.93 | 67.71 | 100.81 | 51.06 | 30.95 | 21.76 | 48.46 | 53.72 | 3.90 | 3.90 | 9.78 | 8.24 |
| Accounts receivable, net | 11.30 | 15.14 | 10.87 | 18.64 | 16.81 | 11.72 | 16.53 | 11.32 | 6.83 | 2.55 | 2.24 | 2.24 | 0.00 | ||||
| Inventories | 3.43 | 0.00 | 0.00 | 2.71 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Other current assets | 5.20 | 38.90 | 4.42 | 4.31 | 10.64 | 3.62 | 4.46 | 3.42 | 1.49 | 0.70 | 0.67 | 1.01 | 0.22 | 0.13 | 0.08 | ||
| Total current assets | 320.15 | 241.69 | 225.69 | 172.33 | 193.65 | 264.26 | 88.70 | 115.55 | 59.38 | 34.25 | 24.67 | 49.47 | 54.95 | 4.59 | 4.59 | 9.91 | 8.33 |
| Total non-current assets | 15.23 | 9.08 | 9.71 | 10.88 | 10.23 | 7.75 | 3.83 | 2.59 | 2.01 | 0.10 | 0.07 | 2.06 | 0.20 | 0.20 | |||
| Total assets | 335.38 | 250.77 | 235.40 | 183.20 | 203.88 | 272.01 | 92.53 | 118.13 | 61.39 | 34.35 | 24.75 | 49.68 | 56.79 | 6.64 | 6.64 | 10.11 | 8.53 |
| Total current liabilities | 57.36 | 45.17 | 22.81 | 15.03 | 11.58 | 9.77 | 7.72 | 18.05 | 23.22 | 3.02 | 3.25 | 3.85 | 4.27 | 7.09 | 7.09 | 3.95 | 3.07 |
| Total non-current liabilities | 280.73 | 110.21 | 6.02 | 7.15 | 7.21 | 5.05 | 1.06 | 3.34 | 10.92 | 1.15 | 1.01 | 43.73 | 39.86 | 33.75 | |||
| Total liabilities | 338.09 | 155.38 | 28.82 | 22.18 | 18.79 | 14.82 | 8.78 | 21.39 | 34.14 | 3.02 | 3.25 | 6.60 | 7.48 | 50.83 | 11.27 | 43.81 | 36.81 |
| Total stockholders' equity | -2.71 | 95.39 | 206.58 | 161.03 | 185.09 | 257.19 | 83.75 | 96.74 | 27.25 | 31.33 | 21.50 | 43.07 | 49.31 | -44.18 | -4.63 | -33.71 | -28.29 |
| Common shares outstanding | 51 | 50 | 37 | 28 | 24 | 19 | 18 | 15 | 10 | 10 | 1 | 1 | 1 | 1 | |||
Show Quarterly Balance Sheet
Balance Sheet - KalVista Pharmaceuticals, Inc. (KALV)
$(Billion, Million)| Apr-26 | Jan-26 | Oct-25 | Jul-25 | Apr-25 | Jan-25 | Oct-24 | Jul-24 | Apr-24 | Jan-24 | Oct-23 | Jul-23 | Apr-23 | Jan-23 | Oct-22 | Jul-22 | Apr-22 | Jan-22 | Oct-21 | Jul-21 | Apr-21 | Jan-21 | Oct-20 | Jul-20 | Apr-20 | Jan-20 | Oct-19 | Jul-19 | Apr-19 | Jan-19 | Oct-18 | Jul-18 | Apr-18 | Jan-18 | Oct-17 | Jul-17 | Apr-17 | Jan-17 | Oct-16 | Jul-16 | Apr-16 | Jan-16 | Oct-15 | Jul-15 | Apr-15 | Jan-15 | Oct-14 | Jul-14 | Apr-14 | Jan-14 | Oct-13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 300.21 | 285.03 | 300.21 | 191.47 | 187.65 | 253.20 | 135.78 | 174.27 | 210.40 | 75.59 | 103.17 | 123.26 | 149.38 | 171.69 | 122.27 | 142.08 | 166.20 | 194.79 | 209.81 | 230.63 | 248.93 | 50.31 | 55.87 | 64.33 | 67.71 | 80.57 | 93.46 | 100.37 | 100.81 | 111.15 | 121.12 | 48.07 | 51.06 | 58.68 | 28.13 | 26.46 | 30.95 | 33.50 | 35.21 | 36.82 | 48.46 | 53.72 | 59.88 | 65.39 | 3.18 | 3.18 | 3.90 | 9.33 | 0.00 | 0.00 | 9.78 |
| Accounts receivable, net | 11.30 | 9.90 | 11.30 | 6.50 | 15.14 | 9.40 | 12.29 | 10.87 | 23.68 | 21.30 | 20.57 | 16.57 | 11.89 | 21.93 | 17.25 | 14.10 | 11.29 | 17.40 | 13.61 | 10.42 | 7.59 | 14.69 | 12.64 | 16.53 | 14.80 | 11.81 | 12.63 | 11.32 | 8.97 | 7.03 | 5.60 | 6.83 | 5.03 | 4.61 | 2.90 | 2.55 | 3.24 | 0.00 | 0.00 | 0.00 | 2.24 | ||||||||||
| Inventories | 3.43 | 4.00 | 3.43 | 0.46 | 0.00 | -21.30 | -20.57 | 2.04 | 2.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 | -0.13 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||||||||
| Other current assets | 5.20 | 7.85 | 5.20 | 7.93 | 38.90 | 4.75 | 16.49 | 5.07 | 4.42 | 4.84 | 25.43 | 26.59 | 6.38 | 8.56 | 7.01 | 28.33 | 27.45 | 19.68 | 24.67 | 19.15 | 15.34 | 4.60 | 1.52 | 15.89 | 4.46 | 3.63 | 2.62 | 2.73 | 3.42 | 3.95 | 1.92 | 1.51 | 1.49 | 2.00 | 1.40 | 0.84 | 0.70 | 1.22 | 0.31 | 0.69 | 0.67 | 1.22 | 3.14 | 1.57 | 1.61 | 1.13 | 0.69 | 0.16 | 0.13 | ||
| Total current assets | 320.15 | 314.21 | 320.15 | 205.90 | 241.69 | 267.36 | 152.27 | 191.63 | 225.69 | 104.10 | 128.61 | 149.84 | 172.33 | 192.13 | 151.22 | 170.41 | 193.65 | 214.46 | 234.48 | 249.78 | 264.26 | 62.50 | 72.08 | 80.23 | 88.70 | 99.01 | 107.89 | 115.72 | 115.55 | 124.06 | 130.07 | 55.19 | 59.38 | 65.71 | 34.14 | 30.19 | 34.25 | 37.95 | 35.81 | 37.96 | 49.47 | 54.95 | 61.45 | 67.00 | 4.31 | 4.31 | 4.59 | 9.49 | 9.91 | ||
| Total non-current assets | 15.23 | 14.71 | 15.23 | 9.61 | 9.08 | 8.63 | 8.56 | 8.56 | 9.71 | 9.87 | 10.14 | 10.49 | 10.88 | 11.34 | 11.62 | 11.91 | 10.23 | 10.59 | 9.33 | 9.35 | 7.75 | 3.70 | 3.37 | 3.68 | 3.83 | 3.93 | 4.17 | 4.17 | 2.59 | 2.46 | 2.49 | 2.43 | 2.01 | 0.95 | 0.60 | 0.59 | 0.10 | 0.10 | 0.05 | 0.05 | 0.21 | 1.85 | 0.63 | 0.60 | 3.40 | 2.85 | 2.06 | 1.37 | 0.20 | ||
| Total assets | 335.38 | 328.92 | 335.38 | 215.51 | 250.77 | 275.99 | 160.83 | 200.20 | 235.40 | 113.97 | 138.74 | 160.33 | 183.20 | 203.47 | 162.84 | 182.32 | 203.88 | 225.05 | 243.81 | 259.13 | 272.01 | 66.21 | 75.45 | 83.90 | 92.53 | 102.94 | 112.06 | 119.88 | 118.13 | 126.53 | 132.56 | 57.62 | 61.39 | 66.66 | 34.74 | 30.78 | 34.35 | 38.05 | 35.86 | 38.01 | 49.68 | 56.79 | 62.08 | 67.60 | 7.71 | 7.71 | 6.64 | 10.86 | 10.11 | ||
| Total current liabilities | 57.36 | 60.82 | 57.36 | 38.38 | 45.17 | 25.62 | 22.16 | 22.41 | 22.81 | 19.13 | 17.75 | 14.13 | 15.03 | 11.61 | 11.32 | 9.73 | 11.58 | 9.65 | 10.11 | 8.23 | 9.77 | 6.52 | 9.54 | 8.46 | 7.72 | 9.76 | 10.47 | 13.97 | 18.05 | 18.83 | 20.94 | 22.90 | 23.22 | 24.08 | 3.51 | 3.84 | 3.02 | 3.20 | 1.89 | 1.93 | 3.85 | 4.27 | 3.79 | 4.17 | 11.01 | 11.01 | 7.09 | 7.56 | 3.95 | ||
| Total non-current liabilities | 280.73 | 287.75 | 280.73 | 136.34 | 110.21 | 105.25 | 4.68 | 4.99 | 6.02 | 6.26 | 6.55 | 6.87 | 7.15 | 7.42 | 7.71 | 8.01 | 7.21 | 7.47 | 6.22 | 6.47 | 5.05 | 1.12 | 0.93 | 1.01 | 1.06 | 3.43 | 3.81 | 4.05 | 3.34 | 3.67 | 4.67 | 8.47 | 10.92 | 14.01 | 0.15 | 0.21 | 1.15 | 0.76 | 0.04 | 0.04 | 2.75 | 3.21 | 3.67 | 4.11 | 45.68 | 6.12 | 43.73 | 42.94 | 39.86 | ||
| Total liabilities | 338.09 | 348.57 | 338.09 | 174.72 | 155.38 | 130.87 | 26.84 | 27.40 | 28.82 | 25.39 | 24.30 | 21.00 | 22.18 | 19.03 | 19.03 | 17.75 | 18.79 | 17.12 | 16.34 | 14.70 | 14.82 | 7.64 | 10.47 | 9.47 | 8.78 | 13.19 | 14.28 | 18.02 | 21.39 | 22.49 | 25.61 | 31.37 | 34.14 | 38.09 | 3.66 | 4.05 | 3.02 | 3.20 | 1.93 | 1.97 | 6.60 | 7.48 | 7.46 | 8.27 | 56.68 | 56.68 | 50.83 | 50.50 | 43.81 | ||
| Total stockholders' equity | -2.71 | -19.65 | -2.71 | 40.79 | 95.39 | 145.13 | 133.99 | 172.80 | 206.58 | 88.58 | 114.45 | 139.34 | 161.03 | 184.44 | 143.81 | 164.57 | 185.09 | 207.94 | 227.47 | 244.43 | 257.19 | 58.57 | 64.98 | 74.44 | 83.75 | 89.75 | 97.79 | 101.87 | 96.74 | 104.03 | 106.95 | 26.25 | 27.25 | 28.57 | 31.08 | 26.73 | 31.33 | 34.85 | 33.94 | 36.04 | 43.07 | 49.31 | 54.62 | 59.32 | -48.97 | -48.97 | -44.18 | -39.64 | -33.71 | ||
| Common shares outstanding | 51 | 51 | 51 | 53 | 50 | 53 | 47 | 46 | 44 | 35 | 35 | 34 | 34 | 34 | 34 | 25 | 25 | 24 | 24 | 24 | 23 | 18 | 18 | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 15 | 11 | 11 | 11 | 10 | 10 | 10 | 8 | 5 | 5 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |